应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
PTC PTC Inc.
已收盘 05-01 16:00:00 EDT
174.96
-2.48
-1.40%
盘后
174.96
+0.00
0.00%
17:24 EDT
最高
177.91
最低
174.15
成交量
198.05万
今开
177.19
昨收
177.44
日振幅
2.12%
总市值
209.17亿
流通市值
196.27亿
总股本
1.20亿
成交额
3.48亿
换手率
1.77%
流通股本
1.12亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
资讯
新帖
简况
PTC 预测季度收入低于预期
Reuters · 04:39
PTC 预测季度收入低于预期
PTC Inc 预计每股收益1.23美元 - 财报前瞻
Reuters · 04-30 05:59
PTC Inc 预计每股收益1.23美元 - 财报前瞻
PTC Therapeutics Inc 预计每股亏损 1.24 美元 - 财报前瞻
Reuters · 04-24
PTC Therapeutics Inc 预计每股亏损 1.24 美元 - 财报前瞻
坎托菲茨杰拉德公司:重申PTC Therapeutics(PTCT.US)评级,由增持调整至增持评级, 目标价45.00美元。
智通财经 · 04-12
坎托菲茨杰拉德公司:重申PTC Therapeutics(PTCT.US)评级,由增持调整至增持评级, 目标价45.00美元。
Rosenblatt:维持PTC(PTC.US)评级,由买入调整至买入评级, 目标价由195.00美元调整至195.00美元。
智通财经 · 04-12
Rosenblatt:维持PTC(PTC.US)评级,由买入调整至买入评级, 目标价由195.00美元调整至195.00美元。
Ptc Inc.盘中异动 股价大跌5.04%
自选股智能写手 · 03-06
Ptc Inc.盘中异动 股价大跌5.04%
自动驾驶无惧霜雪,LG Innotek开发“高性能加热摄像头模块”
爱集微APP · 02-21
自动驾驶无惧霜雪,LG Innotek开发“高性能加热摄像头模块”
PTC Therapeutics Inc 预计每股收益 53 美分 - 财报前瞻
Reuters · 02-17
PTC Therapeutics Inc 预计每股收益 53 美分 - 财报前瞻
经济形势严峻,PTC 季度收入和利润低于预期
Reuters · 02-01
经济形势严峻,PTC 季度收入和利润低于预期
PTC Inc 预计每股收益96美分 - 财报前瞻
Reuters · 01-30
PTC Inc 预计每股收益96美分 - 财报前瞻
BUZZ-PTC Therapeutics因欧洲将下架其肌肉失调药物而下跌
Reuters · 01-26
BUZZ-PTC Therapeutics因欧洲将下架其肌肉失调药物而下跌
更新版 1-欧洲将撤回 PTC Therapeutics 的罕见肌肉疾病药物
Reuters · 01-26
更新版 1-欧洲将撤回 PTC Therapeutics 的罕见肌肉疾病药物
PTC Therapeutics的肌肉失调药物未能获得欧盟监管机构的支持
Reuters · 01-26
PTC Therapeutics的肌肉失调药物未能获得欧盟监管机构的支持
2024年股市明星:惠而浦(WHR.US)、戴文能源(DVN.US)和PTC Inc(PTC.US)将引爆投资热潮?
智通财经网 · 01-22
2024年股市明星:惠而浦(WHR.US)、戴文能源(DVN.US)和PTC Inc(PTC.US)将引爆投资热潮?
创维第一大股东质押1亿股 或为黄宏生“造车”贷款融资
南方都市报 · 2023-12-27
创维第一大股东质押1亿股 或为黄宏生“造车”贷款融资
北陆药业(300016.SZ):对比剂产品获得塔吉克斯坦注册证书
智通财经 · 2023-12-25
北陆药业(300016.SZ):对比剂产品获得塔吉克斯坦注册证书
加载更多
公司概况
公司名称:
PTC Inc.
所属市场:
NASDAQ
上市日期:
--
主营业务:
PTC Inc.于1985年注册成立。该公司是一家全球性软件公司,提供一系列创新的数字解决方案,这些解决方案共同致力于改变实体产品的设计、制造和服务方式。该公司的软件可以在本地、云端或混合模式下交付。该公司的客户包括航空航天和国防、汽车、电子和高科技、工业机械和设备、生命科学、零售和消费品行业的一些世界上最具创新性的公司。该公司通过销售订阅产生收入,其中包括基于期限的内部部署软件许可和相关支持、软件即服务(SaaS)和托管服务;永久许可;支持永久许可;以及专业服务(咨询、实施和培训)。
发行价格:
--
{"stockData":{"symbol":"PTC","market":"US","secType":"STK","nameCN":"PTC Inc.","latestPrice":174.96,"timestamp":1714593600000,"preClose":177.44,"halted":0,"volume":1980473,"hourTrading":{"tag":"盘后","latestPrice":174.96,"preClose":174.96,"latestTime":"17:24 EDT","volume":36909,"amount":6456694.49,"timestamp":1714598699531},"delay":0,"floatShares":112177635,"shares":119552405,"eps":1.981036,"marketStatus":"已收盘","marketStatusCode":5,"change":-2.48,"latestTime":"05-01 16:00:00 EDT","open":177.19,"high":177.91,"low":174.15,"amount":347644328.33273,"amplitude":0.02119,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":1.981036,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1714636800000},"adr":0,"listingDate":629614800000,"adjPreClose":177.44,"adrRate":0,"preHourTrading":{"tag":"盘前","latestPrice":177.44,"preClose":177.44,"latestTime":"09:27 EDT","volume":20,"amount":3548.8,"timestamp":1714570070028},"postHourTrading":{"tag":"盘后","latestPrice":174.96,"preClose":174.96,"latestTime":"17:24 EDT","volume":36909,"amount":6456694.49,"timestamp":1714598699531},"volumeRatio":2.471637},"requestUrl":"/m/hq/s/PTC","defaultTab":"news","newsList":[{"id":"2432630271","title":"PTC 预测季度收入低于预期","url":"https://stock-news.laohu8.com/highlight/detail?id=2432630271","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2432630271?lang=zh_cn&edition=full","pubTime":"2024-05-02 04:39","pubTimestamp":1714595954,"startTime":"0","endTime":"0","summary":" 路透5月1日 - 工业软件生产商PTC 周三预测的季度收入低于预期,同时也略微收紧了全年业绩指引,这表明由于企业紧缩预算, ,对其工业设计和测试软件的需求持续疲软。根据 LSEG 的数据,该公司预计第三季度收入在 5.25 亿美元到 5.4 亿美元之间,低于分析师平均预期的 5.844 亿美元。PTC 收紧了对 2024 年的预测,目前预计收入为 22.7 亿至 23.4 亿美元,而之前的预期为 22.7 亿至 23.6 亿美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2431822496","title":"PTC Inc 预计每股收益1.23美元 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2431822496","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2431822496?lang=zh_cn&edition=full","pubTime":"2024-04-30 05:59","pubTimestamp":1714427949,"startTime":"0","endTime":"0","summary":" * PTC公司 预计在5月1日公布截至2024年3月31日的业绩报告时,季度收入将出现增长。* LSEG 分析师对 PTC 公司的平均预期为每股收益 1.23 美元。该公司 2024 年 1 月 31 日发布的截至 3 月 31 日的每股收益指导值为 1.10 美元至 1.30 美元。* 华尔街对 PTC Inc 的 12 个月目标价中位数为 205.00 美元,高于其上次收盘价 180.68 美元。除非另有说明,否则所有数据均以美元为单位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2429777147","title":"PTC Therapeutics Inc 预计每股亏损 1.24 美元 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2429777147","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2429777147?lang=zh_cn&edition=full","pubTime":"2024-04-24 04:53","pubTimestamp":1713905603,"startTime":"0","endTime":"0","summary":" * PTC Therapeutics Inc 将于4月25日公布截至2024年3月31日的财报,预计该公司的季度收入将出现下降。* 根据LSEG的数据,11位分析师的平均预期显示,这家总部位于新泽西州沃伦的公司的营收将从去年同期的2.2038亿美元降至1.69703亿美元,降幅为23.0%。* LSEG 分析师对 PTC Therapeutics Inc 的平均预期是每股亏损 1.24 美元。* 华尔街对 PTC Therapeutics Inc 的 12 个月目标价中值为 28.00 美元,高于其上次收盘价 25.97 美元。4月23日 - 上一季度业绩。除非另有说明,所有数字均以美元为单位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2426989735","title":"坎托菲茨杰拉德公司:重申PTC Therapeutics(PTCT.US)评级,由增持调整至增持评级, 目标价45.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2426989735","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2426989735?lang=zh_cn&edition=full","pubTime":"2024-04-12 22:05","pubTimestamp":1712930734,"startTime":"0","endTime":"0","summary":"坎托菲茨杰拉德公司:重申PTC Therapeutics(PTCT.US)评级,由增持调整至增持评级, 目标价45.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240412220540876f713f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240412220540876f713f&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2426378519","title":"Rosenblatt:维持PTC(PTC.US)评级,由买入调整至买入评级, 目标价由195.00美元调整至195.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2426378519","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2426378519?lang=zh_cn&edition=full","pubTime":"2024-04-12 19:35","pubTimestamp":1712921714,"startTime":"0","endTime":"0","summary":"Rosenblatt:维持PTC(PTC.US)评级,由买入调整至买入评级, 目标价由195.00美元调整至195.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240412193517876eb4a3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240412193517876eb4a3&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2417440284","title":"Ptc Inc.盘中异动 股价大跌5.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2417440284","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2417440284?lang=zh_cn&edition=full","pubTime":"2024-03-06 02:18","pubTimestamp":1709662718,"startTime":"0","endTime":"0","summary":"北京时间2024年03月06日02时18分,Ptc Inc.股票出现异动,股价急速下跌5.04%。截至发稿,该股报177.79美元/股,成交量27.6169万股,换手率0.23%,振幅4.20%。Ptc Inc.股票所在的软件服务行业中,整体跌幅为3.51%。其相关个股中,Airship Ai Holdings, Inc、Airship Ai Holdings Inc C/Wts 21/12/2028、Dave Inc C/Wts 05/01/2027 涨幅较大,Airship Ai Holdings, Inc、数海信息、Phunware, Inc.较为活跃,换手率分别为593.30%、520.67%、281.60%,振幅较大的相关个股有Dave Inc C/Wts 05/01/2027 、数海信息、Airship Ai Holdings, Inc,振幅分别为206.67%、134.28%、76.97%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024030602183987e76245&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024030602183987e76245&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2413041549","title":"自动驾驶无惧霜雪,LG Innotek开发“高性能加热摄像头模块”","url":"https://stock-news.laohu8.com/highlight/detail?id=2413041549","media":"爱集微APP","top":-1,"share":"https://www.laohu8.com/m/news/2413041549?lang=zh_cn&edition=full","pubTime":"2024-02-21 16:23","pubTimestamp":1708503815,"startTime":"0","endTime":"0","summary":"集微网消息,LG Innotek通过开发适用于严酷冬季条件的“高性能加热摄像头模块”,向主导自动驾驶摄像头市场迈出重要一步。2月20日,LG Innotek宣布开发出用于自动驾驶的高性能加热摄像头模块,采用最先进的精密光学设计技术。该战略旨在确保在自动驾驶摄像头模组市场的领先地位。LG Innotek开发的高性能加热摄像头模块与现有产品相比,功耗更低,同时镜头除霜时间减少一半。LG Innotek正在积极向全球客户推广,目标是在2027年实现量产。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://tech.ifeng.com/c/8XMBO2vmK0y","is_publish_highlight":false,"gpt_icon":0},{"id":"2412611303","title":"PTC Therapeutics Inc 预计每股收益 53 美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2412611303","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2412611303?lang=zh_cn&edition=full","pubTime":"2024-02-17 06:14","pubTimestamp":1708121656,"startTime":"0","endTime":"0","summary":" * PTC Therapeutics Inc 将于2月29日公布截至2023年12月31日的财报,预计该公司的季度收入将有所增长。* 根据LSEG的数据,12位分析师的平均预期显示,这家总部位于新泽西州南普兰菲尔德的公司预计将实现91.2%的营收增长,从去年同期的1.6741亿美元增至3.2095亿美元。* LSEG 分析师对 PTC Therapeutics Inc 的平均预期为每股收益 53 美分。* 华尔街对 PTC Therapeutics Inc 的 12 个月目标价中位数为 25.00 美元,低于其上次收盘价 25.69 美元。2月16日 - 上一季度业绩。除非另有说明,否则所有数据均以美元为单位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2408590004","title":"经济形势严峻,PTC 季度收入和利润低于预期","url":"https://stock-news.laohu8.com/highlight/detail?id=2408590004","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2408590004?lang=zh_cn&edition=full","pubTime":"2024-02-01 06:18","pubTimestamp":1706739497,"startTime":"0","endTime":"0","summary":" 路透1月31日 - 工业软件制造商PTC 周三预测第二季度收入和利润低于预期,因为利率上升迫使企业削减软件预算。PTC的客户包括大众汽车 和印度摩托车生产商Eicher Motors旗下的皇家恩菲尔德 等公司,该公司生产的软件可以帮助企业在产品的整个生命周期内设计、制造和管理产品。PTC是一家生产计算机辅助设计软件的公司,预计截至3月底的季度调整后每股收益为1.10美元至1.30美元,而分析师的预期为1.26美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2407817023","title":"PTC Inc 预计每股收益96美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2407817023","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2407817023?lang=zh_cn&edition=full","pubTime":"2024-01-30 05:17","pubTimestamp":1706563065,"startTime":"0","endTime":"0","summary":" * PTC公司 预计在1月31日公布截至2023年12月31日的财报时,季度收入将出现增长。* LSEG 分析师对 PTC 公司的平均预期为每股收益 96 美分。该公司在 2023 年 11 月 1 日发布的截至 12 月 31 日的每股收益指导值为 0.80 美元至 1.00 美元。* 华尔街对 PTC Inc 的 12 个月目标价中位数为 190.00 美元,高于其最后收盘价 180.65 美元。1月29日 - 上一季度业绩。除非另有说明,所有数字均以美元为单位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2406579879","title":"BUZZ-PTC Therapeutics因欧洲将下架其肌肉失调药物而下跌","url":"https://stock-news.laohu8.com/highlight/detail?id=2406579879","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2406579879?lang=zh_cn&edition=full","pubTime":"2024-01-26 22:04","pubTimestamp":1706277895,"startTime":"0","endTime":"0","summary":" 1月26日 - ** 制药商PTC Therapeutics 股价盘前下跌约10%,至 $24** 周四晚些时候,欧洲卫生监管机构的顾问小组重申了对该公司肌肉失调药物 。** 欧洲委员会将批准该意见,并在 67 天内将该药撤出市场。** 这种名为Translarna的药物于2014年在欧洲获得有条件批准,用于治疗五岁及以上患有杜兴氏肌肉萎缩症的儿童,这种疾病是一种遗传性进行性肌肉萎缩疾病。** Translarna旨在促进一种名为 \"肌营养不良蛋白\"的蛋白质的生产,缺乏这种蛋白质会导致DMD患者肌肉衰弱。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2406922018","title":"更新版 1-欧洲将撤回 PTC Therapeutics 的罕见肌肉疾病药物","url":"https://stock-news.laohu8.com/highlight/detail?id=2406922018","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2406922018?lang=zh_cn&edition=full","pubTime":"2024-01-26 05:52","pubTimestamp":1706219526,"startTime":"0","endTime":"0","summary":" 路透1月25日 - PTC Therapeutics 周四称,欧洲卫生监管机构的顾问小组对其治疗一种遗传性进行性肌肉萎缩症的药物发表了否定意见,导致其股价在盘后交易中下跌近12%。这种名为 Translarna 的药物旨在治疗杜兴氏肌肉萎缩症,这是一种导致肌肉退化的遗传性疾病,几乎总是影响年轻男孩。该公司表示,人用医药产品委员会发表的否定意见将导致该疗法在欧洲的撤消。据美国国家罕见疾病组织称,估计全球每 3500 名男婴中就有一名患有 DMD。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2406222187","title":"PTC Therapeutics的肌肉失调药物未能获得欧盟监管机构的支持","url":"https://stock-news.laohu8.com/highlight/detail?id=2406222187","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2406222187?lang=zh_cn&edition=full","pubTime":"2024-01-26 05:20","pubTimestamp":1706217606,"startTime":"0","endTime":"0","summary":"((自动化翻译由路透提供,请见免责声明 )) 路透1月25日 - 欧洲卫生监管机构顾问小组周四表示,对PTC Therapeutics公司治疗杜兴氏肌肉萎缩症(Duchenne muscular dystrophy(DMD))的 药物持否定意见,这是一种遗传性进行性肌肉萎缩疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2405946551","title":"2024年股市明星:惠而浦(WHR.US)、戴文能源(DVN.US)和PTC Inc(PTC.US)将引爆投资热潮?","url":"https://stock-news.laohu8.com/highlight/detail?id=2405946551","media":"智通财经网","top":-1,"share":"https://www.laohu8.com/m/news/2405946551?lang=zh_cn&edition=full","pubTime":"2024-01-22 15:29","pubTimestamp":1705908592,"startTime":"0","endTime":"0","summary":"惠而浦、戴文能源和PTC Inc这三家公司虽然各不相同,但都有潜力在今年以及未来十年为投资者带来卓越的回报。","market":"us","thumbnail":"https://img.zhitongcaijing.com/image/20240122/20240122153042_35067.png?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/image/20240122/20240122153042_35067.png?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1058956.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2394781856","title":"创维第一大股东质押1亿股 或为黄宏生“造车”贷款融资","url":"https://stock-news.laohu8.com/highlight/detail?id=2394781856","media":"南方都市报","top":-1,"share":"https://www.laohu8.com/m/news/2394781856?lang=zh_cn&edition=full","pubTime":"2023-12-27 18:14","pubTimestamp":1703672085,"startTime":"0","endTime":"0","summary":"12月27日,南都湾财社记者从港交所获悉,当天创维集团发布公告,公司董事会获公司控股股东TargetSuccessGroup(PTC)Limited(TargetSuccess)告知,彼已于2023年12月27日将公司合共1亿股普通股股份质押予澳门国际银行股份有限公司(贷款人),作为贷款人向黄宏生先生控制的一间公司提供贷款融资的担保。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202312272945306267.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2394254590","title":"北陆药业(300016.SZ):对比剂产品获得塔吉克斯坦注册证书","url":"https://stock-news.laohu8.com/highlight/detail?id=2394254590","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2394254590?lang=zh_cn&edition=full","pubTime":"2023-12-25 17:10","pubTimestamp":1703495426,"startTime":"0","endTime":"0","summary":"智通财经APP讯,北陆药业 发布公告,近日,公司收到由塔吉克斯坦卫生部核准签发的碘海醇注射液、钆喷酸葡胺注射液药品注册证书,批准公司碘海醇注射液和钆喷酸葡胺注射液在塔吉克斯坦注册。截止目前,碘海醇注射液、钆喷酸葡胺注射液等对比剂产品已在秘鲁、哥斯达黎加、巴拿马、也门、智利、厄瓜多尔、巴基斯坦、肯尼亚、塔吉克斯坦等国分别以药品、医疗器械身份注册获得上市许可。目前海外销售收入占公司营业总收入比例较低。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1044946.html","is_publish_highlight":false,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.ptc.com","stockEarnings":[{"period":"1week","weight":-0.0166},{"period":"1month","weight":-0.0609},{"period":"3month","weight":-0.0178},{"period":"6month","weight":0.2127},{"period":"1year","weight":0.4125},{"period":"ytd","weight":0.0142}],"compareEarnings":[{"period":"1week","weight":-0.0073},{"period":"1month","weight":-0.0403},{"period":"3month","weight":0.0396},{"period":"6month","weight":0.1653},{"period":"1year","weight":0.2081},{"period":"ytd","weight":0.0561}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"PTC Inc.于1985年注册成立。该公司是一家全球性软件公司,提供一系列创新的数字解决方案,这些解决方案共同致力于改变实体产品的设计、制造和服务方式。该公司的软件可以在本地、云端或混合模式下交付。该公司的客户包括航空航天和国防、汽车、电子和高科技、工业机械和设备、生命科学、零售和消费品行业的一些世界上最具创新性的公司。该公司通过销售订阅产生收入,其中包括基于期限的内部部署软件许可和相关支持、软件即服务(SaaS)和托管服务;永久许可;支持永久许可;以及专业服务(咨询、实施和培训)。","yearOnYearQuotes":[{"month":1,"riseRate":0.628571,"avgChangeRate":0.028903},{"month":2,"riseRate":0.542857,"avgChangeRate":-0.005337},{"month":3,"riseRate":0.571429,"avgChangeRate":-0.011041},{"month":4,"riseRate":0.571429,"avgChangeRate":0.008283},{"month":5,"riseRate":0.676471,"avgChangeRate":0.036402},{"month":6,"riseRate":0.441176,"avgChangeRate":-0.011286},{"month":7,"riseRate":0.588235,"avgChangeRate":0.001548},{"month":8,"riseRate":0.5,"avgChangeRate":0.003329},{"month":9,"riseRate":0.470588,"avgChangeRate":-0.01482},{"month":10,"riseRate":0.647059,"avgChangeRate":0.091438},{"month":11,"riseRate":0.705882,"avgChangeRate":0.050298},{"month":12,"riseRate":0.484848,"avgChangeRate":0.026269}],"exchange":"NASDAQ","name":"PTC Inc.","nameEN":"PTC Inc"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"PTC Inc.(PTC)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供PTC Inc.(PTC)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"PTC Inc.,PTC,PTC Inc.股票,PTC Inc.股票老虎,PTC Inc.股票老虎国际,PTC Inc.行情,PTC Inc.股票行情,PTC Inc.股价,PTC Inc.股市,PTC Inc.股票价格,PTC Inc.股票交易,PTC Inc.股票购买,PTC Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"PTC Inc.(PTC)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供PTC Inc.(PTC)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}